Amlodipine/valsartan

Template:Short description Template:Use dmy dates Template:Cs1 config Template:Short description Template:Template other{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype = combo

| _has_physiological_data= | _has_gene_therapy=

| vaccine_type= | mab_type= | _number_of_combo_chemicals= | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data= | _combo_data=AmlodipineValsartanCalcium channel blockerAngiotensin II receptor antagonist | _physiological_data= | _clinical_data=Template:Drugs.comAmlodipine and valsartan DBy mouthExforge, Copalia, DafiroC09 | _legal_data=Rx-onlyRx-only

| _other_data=

| _image_0_or_2 = Amlodipine.svgValsartan skeletal.svg | _image_LR =

| _datapage = Amlodipine/valsartan (data page) | _vaccine_target=_type_not_vaccine | _legal_all=Rx-onlyRx-only | _ATC_prefix_supplemental=C09 | _has_EMA_link = | CAS_number=1190398-97-0 | PubChem=11354874 | ChemSpiderID=13092186 | ChEBI= | ChEMBL= | DrugBank= | KEGG=D09745 | _hasInChI_or_Key= | UNII= | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =

| _countSecondIDs= | _countIndexlabels= | _trackListSortletter= |QID = |QID2 = |Verifiedfields= |Watchedfields= |verifiedrevid=396294114}}

Amlodipine/valsartan, sold under the brand name Exforge among others, is a blood pressure lowering combination drug. It contains amlodipine, as the besilate, a dihydropyridine-type calcium channel blocker, and valsartan, an angiotensin II receptor antagonist. This combination is usually well tolerated and effective for the reduction of blood pressure.

The combination was approved for medical use in the European Union in January 2007, and in the United States in June 2007.

The combination is also available with hydrochlorothiazide. It was approved for medical use in the United States in April 2009, and in the European Union in November 2009.

References

Template:Asbox